Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KERX | EDIT | GLSI | ||
| Company | Keryx Biopharm Inc | Editas Medicine | Greenwich Lifesciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.44 | 3.59 | 24.52 | ||
| High | 3.46 | 3.59 | 24.83 | ||
| Low | 2.96 | 3.25 | 22.80 | ||
| Latest | 3.36 | 3.30 | 22.91 | ||
| Change | -0.07 | -0.27 | -1.61 | ||
| % Change | -2.04% | -7.56% | -6.57% | ||
| Volume | 2,596,000 | 1,596,700 | 183,200 | ||
| 20-Day Average Volume | 1,773,160 | 1,631,095 | 146,475 | ||
| Previous Close | 3.43 | 3.57 | 24.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.97 | 2.84 | 24.63 | ||
| 20-Day Raw Stochastic | 85.58% | 76.97% | 24.46% | ||
| 20-Day Relative Strength | 57.59 | 65.51 | 45.55 | ||
| Weighted Alpha | -32.40 | +80.14 | +53.95 | ||
| Today's Opinion | N/A | 56% Buy | 48% Buy | ||
| Previous Opinion | N/A | 56% Buy | 48% Buy | ||
| Last Month's Opinion | N/A | 24% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.53% since 12/04/18 | -2.65% since 04/14/26 | -11.95% since 04/14/26 | ||
| Low | 2.95 on 12/06/18 | 3.22 on 04/16/26 | 22.80 on 04/21/26 | ||
| High | 3.51 on 12/11/18 | 3.65 on 04/20/26 | 30.26 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +16.26% since 11/12/18 | +41.03% since 03/20/26 | -4.94% since 03/20/26 | ||
| Low | 2.47 on 11/21/18 | 2.13 on 03/30/26 | 20.53 on 03/30/26 | ||
| High | 3.51 on 12/11/18 | 3.65 on 04/20/26 | 30.26 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +12.37% since 09/12/18 | +55.66% since 01/21/26 | +2.74% since 01/21/26 | ||
| Low | 2.47 on 11/21/18 | 1.66 on 02/05/26 | 20.53 on 03/30/26 | ||
| High | 3.65 on 11/09/18 | 3.65 on 04/20/26 | 34.10 on 01/27/26 | ||
| 6-Month | |||||
| %Chg | -33.60% since 06/12/18 | -14.95% since 10/21/25 | +150.11% since 10/21/25 | ||
| Low | 2.47 on 11/21/18 | 1.66 on 02/05/26 | 7.78 on 11/24/25 | ||
| High | 5.30 on 06/20/18 | 3.87 on 10/24/25 | 34.10 on 01/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 343,997 | 349,403 | 339,724 | ||
| Shares Outstanding, K | 102,380 | 97,872 | 13,855 | ||
| Annual Sales | 60,640,000 | 40,520,000 | 0 | ||
| Annual Net Income | -163,440,000 | -160,060,000 | -15,790,000 | ||
| Last Quarter Sales | 28,040,000 | 24,740,000 | 0 | ||
| Last Quarter Net Income | -17,000,000 | -5,620,000 | -4,150,000 | ||
| 60-Month Beta | 2.35 | 2.04 | 1.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 02/07/18 | -0.06 on 03/09/26 | -0.30 on 11/14/25 | ||
| Latest Earnings Date | 02/06/19 | 05/11/26 | 05/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||